Case Control Study
Copyright ©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 366-378
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.366
Table 7 Logistic regression analysis of factors associated with metabolic-associated fatty liver disease (people living with human immunodeficiency virus and metabolic-associated fatty liver disease vs people living with human immunodeficiency virus and non-metabolic-associated fatty liver disease)
FactorExp(B)95%CIP value
AST4.6151.081-19.7090.039a
Fasting Plasma glucose21.55.327-86.767< 0.001a
Triglyceride6.7471.747-26.0470.006a
Total cholesterol0.1250.019-0.8190.030a
LDL12.971.983-84.8270.007a
APOB rs104957124.1951.304-18.5320.019a
APOA5 rs6627990.0120.002-0.770< 0.001a
LEP rs77990390.3210.070-1.4690.143a